AngioDynamics Upgraded to Buy at Canaccord, PT Raised $3.75; Shares Level Pre Bell

Analysts at Canaccord Genuity have upgraded their coverage of medical device maker AngioDynamics (ANGO) to buy from a hold.

The firm also raised its price target on the stock to $20 from $16.25 a share.

In pre-market activity, shares of ANGO are steady at $15.31, and trade within a 52-week spread of $10.53 – $19.

AngioDynamics, Inc. designs, manufactures, and sells medical, surgical, and diagnostic devices. The company offers manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases; and venous products, including laser system products used in endovascular laser procedures to treat superficial venous diseases, as well as sclerosing drugs that are used in the treatment of small uncomplicated varicose veins of the lower extremities.

About

POST YOUR COMMENTS